Cargando…
Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
BACKGROUND: Persons with schizophrenia are reported to be more likely to die from cardiovascular illness than those in the general population, and are at a greater risk of developing obesity, diabetes type 2, hypertension and dyslipidemias. Antipsychotic drugs used in the treatment of schizophrenia...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136014/ https://www.ncbi.nlm.nih.gov/pubmed/21772644 http://dx.doi.org/10.4103/0019-5545.82537 |